Matū Fund

Matū Fund is a New Zealand-based venture capital firm specializing in early-stage investments in science and technology companies, particularly those in the deep tech and healthcare sectors. The firm operates with a hands-on, active approach, providing both financial and intellectual capital to its portfolio companies. This support includes expert governance, executive management, operational assistance, and mentorship, all aimed at transforming groundbreaking scientific ideas into globally focused, IP-rich companies.

The firm's investment strategy focuses on identifying and nurturing early-stage companies with strong intellectual property and significant global commercial potential. Matū Fund seeks to invest in ideas that can disrupt large markets and achieve global reach, emphasizing the importance of a clear go-to-market pathway and passionate founders. The firm is committed to adding value beyond capital, leveraging its team's extensive experience in science and technology to guide companies toward success.

Matū Fund's portfolio includes companies such as Mekonos, Synthase Biotech, and Advemto, reflecting its dedication to supporting innovative ventures in the science and technology sectors. The firm's values, including guardianship, integrity, bravery, and passion, guide its investment decisions and interactions, ensuring a long-term, intergenerational approach to building a fund that contributes positively to society and the world.